Clover Signs COVID-19 Vaccine Supply Agreement with UNICEF
CHENGDU, China, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; Stock code: 2197.HK), a global clinical-stage biotechnology company...
News
Healthcare Triangle to Present at Sidoti December Virtual Microcap Conference
PLEASANTON, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company"), a leading provider...
Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development
Science 37 enhances its Operating Systems, adding ability to deploy its technology platform into China and Russia and strengthening global...
Harpoon Therapeutics to Host Pipeline Update Call and Webcast on December 13, 2021
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement
Screening identifies several unique compound series that inhibit the SARS-CoV-2 nsp5 main protease, a validated target for the treatment of...
Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
CARLSBAD, Calif. , Dec. 07, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:...
CorVel Launches New Workers’ Compensation and Liability Solution, Leveraging Artificial Intelligence and Predictive Analytics
CogencyIQ helps risk managers and claims professionals navigate increasingly complex claims and massive amounts of data to improve outcomes for...
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial...
Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe
Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe First round of pricing negotiations completed in the...
Jushi Holdings Inc. Announces Participation in Upcoming Conferences in December 2021
BOCA RATON, Fla., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC Series A round led by Pontifax and includes...
Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Phase 1 trial achieved primary objective of safety and tolerability and demonstrated favorable outcomes on other key endpoints, including target...
MediPharm Labs Announces Changes to Board of Directors
BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or...
Simply Better Brands Corp. Announces USD$2.6 Million Monthly Revenue for November 2021
Second Consecutive Month of Higher Growth Over Q3 Average Monthly SalesVANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Simply...
Clene Nanomedicine’s RESCUE-ALS Phase 2 Results Selected for Late-Breaking Presentation at 32nd International Symposium on ALS/MND
Late-breaker oral presentation by Professor Steve Vucic, University of Sydney Medical School and Northcott Chair of NeurologyCNM-Au8® demonstrated significantly slowed disease...
MIMEDX Outlines Long-Term Value Creation Strategy at Virtual Investor Day
Company to Share Probability Values from its Knee Osteoarthritis (KOA) Study; Analyses Conducted Support Confidence in Initiation of Confirmatory Phase...
HEXO to Report Q1 2022 Financial Results and Host Investor Webcast
GATINEAU, Quebec, Dec. 07, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NASDAQ: HEXO) plans to...
Information about the end of mandatory offer of share repurchase
Joint Stock Company “Olainfarm” hereby informs that today, 7th December 2021 at 16:00 JSC AB CITY will end the mandatory...
Philips again recognized with prestigious ‘A’ score for its climate action leadership
Refurbishment process December 7, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health...
Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19
EMA’s CHMP recommended the approval yesterdayApproval based on results from four phase III studies in over 5,500 patientsActemra/RoActemra has also...
